These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vascular endothelial growth factor (VEGF165) plasma level increase with immunodepression in AIDS patients with Kaposi's sarcoma. Mercié P, Devianne I, Viallard JF, Faure I, Pellegrin I, Leng B, Dupon M, Barbeau P, Fleury H, Pellegrin JL. Microvasc Res; 1999 Mar; 57(2):208-10. PubMed ID: 10049669 [No Abstract] [Full Text] [Related]
3. Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts. Samaniego F, Young D, Grimes C, Prospero V, Christofidou-Solomidou M, DeLisser HM, Prakash O, Sahin AA, Wang S. Cell Growth Differ; 2002 Aug; 13(8):387-95. PubMed ID: 12193477 [Abstract] [Full Text] [Related]
4. Vascular endothelial growth factor and basic fibroblast growth factor in melanoma. Weber F, Sepp N, Fritsch P. Br J Dermatol; 2000 Feb; 142(2):392-3. PubMed ID: 10730793 [No Abstract] [Full Text] [Related]
5. Serum levels of vascular endothelial growth factor in a haemangiosarcoma patient with a newly typed p53 gene point mutation. Amo Y, Masuzawa M, Hamada Y, Takasu H, Fujimura T, Katsuoka K, Tamauchi H. Br J Dermatol; 2000 Nov; 143(5):1118-9. PubMed ID: 11069548 [No Abstract] [Full Text] [Related]
6. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. Skobe M, Brown LF, Tognazzi K, Ganju RK, Dezube BJ, Alitalo K, Detmar M. J Invest Dermatol; 1999 Dec; 113(6):1047-53. PubMed ID: 10594750 [Abstract] [Full Text] [Related]
7. Circulating endothelial progenitor cells are increased in patients with classic Kaposi's sarcoma. Taddeo A, Presicce P, Brambilla L, Bellinvia M, Villa ML, Della Bella S. J Invest Dermatol; 2008 Aug; 128(8):2125-8. PubMed ID: 18305570 [No Abstract] [Full Text] [Related]
8. Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: implications for acquired immunodeficiency syndrome-associated vasculopathy. Ascherl G, Hohenadl C, Schatz O, Shumay E, Bogner J, Eckhart L, Tschachler E, Monini P, Ensoli B, Stürzl M. Blood; 1999 Jun 15; 93(12):4232-41. PubMed ID: 10361120 [Abstract] [Full Text] [Related]
9. Vascular endothelial growth factor levels in serum do not increase following HIV type 1 and HHV8 seroconversion and lack correlation with AIDS-related Kaposi's sarcoma. Renwick N, Weverling GJ, Brouwer J, Bakker M, Schulz TF, Goudsmit J. AIDS Res Hum Retroviruses; 2002 Jul 01; 18(10):695-8. PubMed ID: 12167275 [Abstract] [Full Text] [Related]
10. Serum concentrations of vascular endothelial growth factor in angiosarcomas with and without p53 gene mutation. Amo Y, Masuzawa M, Hamada Y, Katsuoka K. Acta Derm Venereol; 2002 Jul 01; 82(5):373-4. PubMed ID: 12430738 [No Abstract] [Full Text] [Related]
11. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Flore O, Rafii S, Ely S, O'Leary JJ, Hyjek EM, Cesarman E. Nature; 1998 Aug 06; 394(6693):588-92. PubMed ID: 9707121 [Abstract] [Full Text] [Related]
12. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Brown LF, Tognazzi K, Dvorak HF, Harrist TJ. Am J Pathol; 1996 Apr 06; 148(4):1065-74. PubMed ID: 8644848 [Abstract] [Full Text] [Related]
13. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gershengorn MC, Mesri EA. Nature; 1998 Jan 01; 391(6662):86-9. PubMed ID: 9422510 [Abstract] [Full Text] [Related]
14. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. Cianfrocca M, Cooley TP, Lee JY, Rudek MA, Scadden DT, Ratner L, Pluda JM, Figg WD, Krown SE, Dezube BJ. J Clin Oncol; 2002 Jan 01; 20(1):153-9. PubMed ID: 11773164 [Abstract] [Full Text] [Related]
15. Kaposi's sarcoma. Coupling herpesvirus to angiogenesis. Boshoff C. Nature; 1998 Jan 01; 391(6662):24-5. PubMed ID: 9422503 [No Abstract] [Full Text] [Related]
17. Basic fibroblast growth factor as a growth factor for SRV-2-infected simian retroperitoneal fibromatosis cells, an animal model for AIDS related Kaposi's sarcoma. Chung CH, Chiang J, Jiang CM, Chen YY, Huang CY, Chen PG, Chen YJ. Neoplasma; 2001 Nov 01; 48(3):192-9. PubMed ID: 11583288 [Abstract] [Full Text] [Related]
18. Vascular endothelial growth factor platelet counts and renal cancer. Gunsilius E, Petzer AL, Gastl G. Lancet; 1999 Jun 26; 353(9171):2247. PubMed ID: 10393017 [No Abstract] [Full Text] [Related]
19. Vascular endothelial growth factor: promise or peril? Kipshidze N. Am J Cardiol; 1999 Jun 01; 83(11):1592. PubMed ID: 10363882 [No Abstract] [Full Text] [Related]
20. Vascular endothelial growth factor platelet counts, and prognosis in renal cancer. O'Byrne KJ, Dobbs N, Propper D, Smith K, Harris AL. Lancet; 1999 May 01; 353(9163):1494-5. PubMed ID: 10232320 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]